AlphaFold predicted structure
METTL5 · Q9NRN9

Mean pLDDT
92.6/ 100
Very high
209 residues
Confidence breakdown
- Very high(≥ 90)81%
- Confident(70–90)12%
- Low(50–70)6%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
methyltransferase 5, N6-adenosine
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalSevere microcephaly
BIALLELIC, autosomal or pseudoautosomalintellectual developmental disorder, autosomal recessive 72
Severe intellectual disability
microcephaly with intellectual disability
autosomal recessive primary microcephaly
neurodegenerative disease
hereditary disease
hepatocellular carcinoma
gastric cancer
preeclampsia
diabetes mellitus
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
rRNA N(6)-adenosine-methyltransferase METTL5
Catalytic subunit of a heterodimer with TRMT112, which specifically methylates the 6th position of adenine in position 1832 of 18S rRNA (PubMed:31328227, PubMed:32217665, PubMed:33357433, PubMed:33428944, PubMed:35033535). N6-methylation of adenine(1832) in 18S rRNA resides in the decoding center of 18S rRNA and is required for translation and embryonic stem cells (ESCs) pluripotency and differentiation (PubMed:33357433)
METTL5 · Q9NRN9

Mean pLDDT
92.6/ 100
Very high
209 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0